These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25308264)

  • 21. [Chromatin immunoprecipitation and its preliminary application for gene regulation].
    Zhang Y; Cheng XK; Wu NH; Shen YF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):52-5. PubMed ID: 15052775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcriptional activities of mutant p53: when mutations are more than a loss.
    Kim E; Deppert W
    J Cell Biochem; 2004 Nov; 93(5):878-86. PubMed ID: 15449312
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ING1 represses transcription by direct DNA binding and through effects on p53.
    Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K
    Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA topoisomerase III alpha regulates p53-mediated tumor suppression.
    Hsieh MY; Fan JR; Chang HW; Chen HC; Shen TL; Teng SC; Yeh YH; Li TK
    Clin Cancer Res; 2014 Mar; 20(6):1489-501. PubMed ID: 24526736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 regulates its own activator: transcriptional co-activator PC4, a new p53-responsive gene.
    Kishore AH; Batta K; Das C; Agarwal S; Kundu TK
    Biochem J; 2007 Sep; 406(3):437-44. PubMed ID: 17555406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. eRNAs are required for p53-dependent enhancer activity and gene transcription.
    Melo CA; Drost J; Wijchers PJ; van de Werken H; de Wit E; Oude Vrielink JA; Elkon R; Melo SA; Léveillé N; Kalluri R; de Laat W; Agami R
    Mol Cell; 2013 Feb; 49(3):524-35. PubMed ID: 23273978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear p53-mediated repression of autophagy involves PINK1 transcriptional down-regulation.
    Goiran T; Duplan E; Rouland L; El Manaa W; Lauritzen I; Dunys J; You H; Checler F; Alves da Costa C
    Cell Death Differ; 2018 May; 25(5):873-884. PubMed ID: 29352272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The p53 response element and transcriptional repression.
    Wang B; Xiao Z; Ko HL; Ren EC
    Cell Cycle; 2010 Mar; 9(5):870-9. PubMed ID: 20160511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis.
    Nikulenkov F; Spinnler C; Li H; Tonelli C; Shi Y; Turunen M; Kivioja T; Ignatiev I; Kel A; Taipale J; Selivanova G
    Cell Death Differ; 2012 Dec; 19(12):1992-2002. PubMed ID: 22790872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of NEEP21, encoding neuron-enriched endosomal protein of 21 kDa, as a transcriptional target of tumor suppressor p53.
    Ohnishi S; Futamura M; Kamino H; Nakamura Y; Kitamura N; Miyamoto Y; Miyamoto T; Shinogi D; Goda O; Arakawa H
    Int J Oncol; 2010 Nov; 37(5):1133-41. PubMed ID: 20878061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of UNC5A as a novel transcriptional target of tumor suppressor p53 and a regulator of apoptosis.
    Miyamoto Y; Futamura M; Kitamura N; Nakamura Y; Baba H; Arakawa H
    Int J Oncol; 2010 May; 36(5):1253-60. PubMed ID: 20372800
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P53 transcriptional activities: a general overview and some thoughts.
    Millau JF; Bastien N; Drouin R
    Mutat Res; 2009; 681(2-3):118-133. PubMed ID: 18639648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson.
    Menendez D; Inga A; Jordan JJ; Resnick MA
    Oncogene; 2007 Apr; 26(15):2191-201. PubMed ID: 17401428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of p53 protein aggregation in cancer cell lines and tumor samples.
    Yang-Hartwich Y; Bingham J; Garofalo F; Alvero AB; Mor G
    Methods Mol Biol; 2015; 1219():75-86. PubMed ID: 25308263
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p53 binding sites in normal and cancer cells are characterized by distinct chromatin context.
    Bao F; LoVerso PR; Fisk JN; Zhurkin VB; Cui F
    Cell Cycle; 2017; 16(21):2073-2085. PubMed ID: 28820292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mediates the suppression of cancer cell invasion by inducing LIMA1/EPLIN.
    Ohashi T; Idogawa M; Sasaki Y; Tokino T
    Cancer Lett; 2017 Apr; 390():58-66. PubMed ID: 28093207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chromatin immunoprecipitation-based screen to identify functional genomic binding sites for sequence-specific transactivators.
    Hearnes JM; Mays DJ; Schavolt KL; Tang L; Jiang X; Pietenpol JA
    Mol Cell Biol; 2005 Nov; 25(22):10148-58. PubMed ID: 16260627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does Nrf2 contribute to p53-mediated control of cell survival and death?
    Chen W; Jiang T; Wang H; Tao S; Lau A; Fang D; Zhang DD
    Antioxid Redox Signal; 2012 Dec; 17(12):1670-5. PubMed ID: 22559194
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Kurtz P; Jones AE; Tiwari B; Link N; Wylie A; Tracy C; Krämer H; Abrams JM
    Mol Biol Cell; 2019 May; 30(11):1339-1351. PubMed ID: 30892991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.